However, in one study (187) involving the murine neuroblastoma cell line Neuro2A, a low concentration (0.1 nM) of the selective GRPR antagonist RC-3095 inhibited cell growth, but with a higher concentration (100 nM), it stimulated growth. Here, GRPR is linked to neuroblastoma.